Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bertelsen

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Blood transfusion and prognosis in Dukes' B and C colorectal cancerS M Bentzen, I Balslev, M Pedersen, et al.
Ugeskrift for Laeger|January 14, 1991
[Treatment of cervix cancer in Denmark]A K Jakobsen, K Bertelsen, B Andreasson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Intergroup collaboration in ovarian cancer: a giant step forwardM J Piccart, G C Stuart, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced epithelial ovarian cancer: 1993 consensus statementsD G Allen, J Baak, D Belpomme, et al.
Lancet (London, England)|February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaI Vergote, J De Brabanter, A Fyles, et al.
British Journal of Cancer|October 1, 1982
Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre studyI Balslev, M Pedersen, P S Teglbjaerg, et al.
Ugeskrift for Laeger|May 26, 1997
[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group]H K Poulsen, M Jacobsen, K Bertelsen, et al.
Thorax|December 21, 2010
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trialBarbara M Fischer, Jann Mortensen, Hanne Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experienceC Tropé, T Hogberg, J Kaern, et al.
British Journal of Cancer|September 24, 2004
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancerN E Schoemaker, I E L M Kuppens, V Moiseyenko, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Blood transfusion and prognosis in Dukes' B and C colorectal cancerS M Bentzen, I Balslev, M Pedersen, et al.
Ugeskrift for Laeger|January 14, 1991
[Treatment of cervix cancer in Denmark]A K Jakobsen, K Bertelsen, B Andreasson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Intergroup collaboration in ovarian cancer: a giant step forwardM J Piccart, G C Stuart, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced epithelial ovarian cancer: 1993 consensus statementsD G Allen, J Baak, D Belpomme, et al.
Lancet (London, England)|February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaI Vergote, J De Brabanter, A Fyles, et al.
British Journal of Cancer|October 1, 1982
Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre studyI Balslev, M Pedersen, P S Teglbjaerg, et al.
Ugeskrift for Laeger|May 26, 1997
[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group]H K Poulsen, M Jacobsen, K Bertelsen, et al.
Thorax|December 21, 2010
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trialBarbara M Fischer, Jann Mortensen, Hanne Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experienceC Tropé, T Hogberg, J Kaern, et al.
British Journal of Cancer|September 24, 2004
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancerN E Schoemaker, I E L M Kuppens, V Moiseyenko, et al.
Pageof 8